These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 32110554)

  • 21. CaMKKβ regulates proliferation, apoptosis, and glycolysis of hepatocellular carcinoma via PI3K/AKT pathway.
    Sheng T; Mao XB; Zhang SH
    Ann Palliat Med; 2020 Nov; 9(6):3857-3869. PubMed ID: 33222471
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Shikonin Suppresses Skin Carcinogenesis via Inhibiting Cell Proliferation.
    Li W; Zhang C; Ren A; Li T; Jin R; Li G; Gu X; Shi R; Zhao Y
    PLoS One; 2015; 10(5):e0126459. PubMed ID: 25961580
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Design, synthesis and biological evaluation of novel modified dual-target shikonin derivatives for colorectal cancer treatment.
    Ma Y; Lai X; Wen Z; Zhou Z; Yang M; Chen Q; Wang X; Mei F; Yang L; Yin T; Sun S; Lu G; Qi J; Lin H; Han H; Yang Y
    Bioorg Chem; 2023 Oct; 139():106703. PubMed ID: 37399615
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Sonosensitizer Nanoplatforms Augmented Sonodynamic Therapy-Sensitizing Shikonin-Induced Necroptosis Against Hepatocellular Carcinoma.
    Tian H; Shang H; Chen Y; Wu B; Wang C; Wang X; Cheng W
    Int J Nanomedicine; 2023; 18():7079-7092. PubMed ID: 38050474
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Inhibition of PKM2 suppresses osteoclastogenesis and alleviates bone loss in mouse periodontitis.
    Li F; Liu X; Li M; Wu S; Le Y; Tan J; Zhu C; Wan Q
    Int Immunopharmacol; 2024 Mar; 129():111658. PubMed ID: 38359663
    [TBL] [Abstract][Full Text] [Related]  

  • 26. PKM2 Is Overexpressed in Glioma Tissues, and Its Inhibition Highly Increases Late Apoptosis in U87MG Cells With Low-density Specificity.
    Park JH; Lee JS; Oh Y; Lee JS; Park HE; Lee H; Park YS; Kyung SY; Kim HS; Yoon S
    In Vivo; 2022; 36(2):694-703. PubMed ID: 35241524
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Inhibition of Pyruvate Kinase M2 Markedly Reduces Chemoresistance of Advanced Bladder Cancer to Cisplatin.
    Wang X; Zhang F; Wu XR
    Sci Rep; 2017 Apr; 7():45983. PubMed ID: 28378811
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A novel multitarget kinase inhibitor BZG with potent anticancer activity in vitro and vivo enhances efficacy of sorafenib through PI3K pathways in hepatocellular carcinoma cells.
    Wang L; Zhan Y; Wu Z; Lin M; Jin X; Jiang L; Qiu Y
    Biomed Pharmacother; 2020 May; 125():110033. PubMed ID: 32187962
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Shikonin exerts antitumor activity by causing mitochondrial dysfunction in hepatocellular carcinoma through PKM2-AMPK-PGC1α signaling pathway.
    Liu B; Jin J; Zhang Z; Zuo L; Jiang M; Xie C
    Biochem Cell Biol; 2019 Aug; 97(4):397-405. PubMed ID: 30475643
    [TBL] [Abstract][Full Text] [Related]  

  • 30. SH2 domain-containing phosphatase 1 regulates pyruvate kinase M2 in hepatocellular carcinoma.
    Tai WT; Hung MH; Chu PY; Chen YL; Chen LJ; Tsai MH; Chen MH; Shiau CW; Boo YP; Chen KF
    Oncotarget; 2016 Apr; 7(16):22193-205. PubMed ID: 26959741
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Antitumor Effect of Shikonin, a PKM2 Inhibitor, in Cholangiocarcinoma Cell Lines.
    Thonsri U; Seubwai W; Waraasawapati S; Wongkham S; Boonmars T; Cha'on U; Wongkham C
    Anticancer Res; 2020 Sep; 40(9):5115-5124. PubMed ID: 32878800
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pyruvate kinase M2 prevents apoptosis via modulating Bim stability and associates with poor outcome in hepatocellular carcinoma.
    Hu W; Lu SX; Li M; Zhang C; Liu LL; Fu J; Jin JT; Luo RZ; Zhang CZ; Yun JP
    Oncotarget; 2015 Mar; 6(9):6570-83. PubMed ID: 25788265
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of shRNA-Mediated Silencing of PKM2 Gene on Aerobic Glycolysis, Cell Migration, Cell Invasion, and Apoptosis in Colorectal Cancer Cells.
    Yan XL; Zhang XB; Ao R; Guan L
    J Cell Biochem; 2017 Dec; 118(12):4792-4803. PubMed ID: 28543190
    [TBL] [Abstract][Full Text] [Related]  

  • 34. PKM2 promotes cell metastasis and inhibits autophagy via the JAK/STAT3 pathway in hepatocellular carcinoma.
    Yu Z; Wang D; Tang Y
    Mol Cell Biochem; 2021 May; 476(5):2001-2010. PubMed ID: 33512635
    [TBL] [Abstract][Full Text] [Related]  

  • 35. PKM2 Drives Hepatocellular Carcinoma Progression by Inducing Immunosuppressive Microenvironment.
    Li TE; Wang S; Shen XT; Zhang Z; Chen M; Wang H; Zhu Y; Xu D; Hu BY; Wei R; Zheng Y; Dong QZ; Qin LX
    Front Immunol; 2020; 11():589997. PubMed ID: 33193421
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Efficacy of RNAi targeting of pyruvate kinase M2 combined with cisplatin in a lung cancer model.
    Guo W; Zhang Y; Chen T; Wang Y; Xue J; Zhang Y; Xiao W; Mo X; Lu Y
    J Cancer Res Clin Oncol; 2011 Jan; 137(1):65-72. PubMed ID: 20336315
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The PKM2 inhibitor shikonin enhances piceatannol-induced apoptosis of glyoxalase I-dependent cancer cells.
    Inoue M; Nakagawa Y; Azuma M; Akahane H; Chimori R; Mano Y; Takasawa R
    Genes Cells; 2024 Jan; 29(1):52-62. PubMed ID: 37963646
    [TBL] [Abstract][Full Text] [Related]  

  • 38. STIP1 down-regulation inhibits glycolysis by suppressing PKM2 and LDHA and inactivating the Wnt/β-catenin pathway in cervical carcinoma cells.
    Li R; Li P; Wang J; Liu J
    Life Sci; 2020 Oct; 258():118190. PubMed ID: 32777299
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [The Effect of si-PKM2 on Proliferation and Apoptosis of Acute Leukemic Cells and Its Molecular Mechanism].
    Li LY; Nie ZY; Zhang XY; Luo JM; Yang L; Wang Q; Wang XZ
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2021 Oct; 29(5):1394-1402. PubMed ID: 34627416
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Inhibition of Pyruvate kinase M2 (PKM2) by shikonin attenuates isoproterenol-induced acute myocardial infarction via reduction in inflammation, hypoxia, apoptosis, and fibrosis.
    Rihan M; Sharma SS
    Naunyn Schmiedebergs Arch Pharmacol; 2024 Jan; 397(1):145-159. PubMed ID: 37382601
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.